U of A virologist David Evans (right) and research associate Ryan Noyce are teaming up with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19, targeting the “spike” protein the coronavirus uses to enter cells and cause infection. (Photo: Melissa Fabrizio)

U of A researchers and Tonix Pharmaceuticals race to develop and test candidate vaccines for COVID-19

Posted on

Partnerships like this one can dramatically accelerate efforts to move research from lab to community, says virologist.

University of Alberta researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19.

The researchers hope their unique delivery method for the vaccine—synthetic vaccinia and horsepox viruses—will prove more effective than others being tested around the world….

https://www.folio.ca/u-of-a-researchers-and-tonix-pharmaceuticals-race-to-develop-and-test-candidate-vaccines-for-covid-19/

Read More Impact Stories

Posted on
For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Posted on
McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Posted on
Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]